We are live on
!
Find out more
AC
Ascend Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
10.36%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+10.36%
3 Year Est. Return
+56.79%
5 Year Est. Return
+86.43%
10 Year Est. Return
–
AUM
$2.61B
AUM Growth
-$775M
(-23%)
Cap. Flow
-$879M
Cap. Flow
% of AUM
-33.74%
Top 10 Holdings %
Top 10 Hldgs %
21.13%
Holding
237
New
65
Increased
27
Reduced
59
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntsman Corp
HUN
|
+$67.9M |
| 2 |
Gilead Sciences
GILD
|
+$53.1M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$52.9M |
| 4 |
Constellation Brands
STZ
|
+$52.2M |
| 5 |
CDK
CDK Global, Inc.
CDK
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$87.2M |
| 2 |
Pentair
PNR
|
+$71.5M |
| 3 |
DISH
DISH Network Corp.
DISH
|
+$58.9M |
| 4 |
Liberty Media Series C
FWONK
|
+$50.9M |
| 5 |
Liberty Media Series A
FWONA
|
+$50.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.14% |
| 2 | Financials | 14.87% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 11.53% |
| 5 | Consumer Discretionary | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola Europacific Partners
CCEP
$49.1B
| $31.8M | 1.22% |
+718,970
| New | +$31M |
|
27
Signet Jewelers
SIG
$3.84B
| $31.8M | 1.22% |
+241,420
| New | +$29.2M |
|
|
ROC
28
DELISTED
ROCKWOOD HLDGS INC
ROC
| $30.8M | 1.18% |
391,102
-61,252
| -14% | -$4.72M |
|
|
JAH
29
DELISTED
JARDEN CORPORATION
JAH
| $29M | 1.11% |
604,655
-125,850
| -17% | -$5.47M |
|
|
LTRPA
30
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $28.9M | 1.11% |
1,075,000
+450,000
| +72% | +$12.5M |
|
31
Bank of America
BAC
$429B
| $28.9M | 1.11% |
1,615,751
+988,141
| +157% | +$16.9M |
|
32
Tyson Foods
TSN
$21.5B
| $27.9M | 1.07% |
695,924
-333,370
| -32% | -$13.5M |
|
33
Ally Financial
ALLY
$13.1B
| $27.8M | 1.07% |
+1,178,540
| New | +$26.7M |
|
34
Motorola Solutions
MSI
$72.1B
| $27M | 1.04% |
403,114
+64,723
| +19% | +$4.13M |
|
35
Trane Technologies
TT
$98.8B
| $26.6M | 1.02% |
419,751
-163,604
| -28% | -$9.99M |
|
|
WCC
36
WESCO International
WCC
$15.1B
| $24.9M | 0.95% |
326,270
+166,270
| +104% | +$13.1M |
|
37
Bausch Health
BHC
$1.75B
| $24.5M | 0.94% |
171,331
-76,779
| -31% | -$10.3M |
|
38
Pfizer
PFE
$143B
| $24.5M | 0.94% |
828,287
-1,699,756
| -67% | -$48.7M |
|
39
Advance Auto Parts
AAP
$3.53B
| $24.2M | 0.93% |
152,067
-48,627
| -24% | -$7.14M |
|
|
SGEN
40
DELISTED
Seagen Inc. Common Stock
SGEN
| $24.1M | 0.92% |
+750,000
| New | +$26.1M |
|
|
WFM
41
DELISTED
Whole Foods Market Inc
WFM
| $23.4M | 0.9% |
+463,400
| New | +$20.4M |
|
42
CALL
GSK
GSK
$107B
| $22.7M | 0.87% |
+424,720
| New | +$23.8M |
|
43
Berkshire Hathaway Class B
BRK.B
$1.1T
| $22M | 0.85% |
146,733
-148,144
| -50% | -$21.4M |
|
44
iShares US Home Construction ETF
ITB
$2.32B
| $21.4M | 0.82% |
+825,000
| New | +$20.1M |
|
45
Aramark
ARMK
$15B
| $21.2M | 0.81% |
+942,943
| New | +$19.3M |
|
46
VeriSign
VRSN
$26.3B
| $20.1M | 0.77% |
352,771
-353,136
| -50% | -$20.4M |
|
|
ENDP
47
DELISTED
Endo International plc
ENDP
| $20M | 0.77% |
+276,953
| New | +$19M |
|
48
Bread Financial
BFH
$4.32B
| $19.7M | 0.76% |
86,332
-11,455
| -12% | -$2.51M |
|
|
AAN.A
49
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $18.8M | 0.72% |
615,107
+196,182
| +47% | +$6M |
|
50
Molson Coors Class B
TAP
$8.02B
| $18.8M | 0.72% |
251,961
-149,683
| -37% | -$11.1M |
|
Similar funds
MWAC
TP
PC
RW
TBC
BWCA
AC
GCM
Ascend Capital's Q4 2014 Portfolio in Review
As of Q4 2014, Ascend Capital held 237 positions worth $2.61B, down 23% from $3.38B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ascend Capital withdrew a net $879M in Q4 2014, closing 82 positions and reducing 59 holdings. Its most notable exit was Honeywell, an estimated $87.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ascend Capital opened a new position in Huntsman Corp worth $63.8M.
- Ascend Capital's largest Q4 2014 buy was Huntsman Corp: 2,799,273 shares worth $63.8M.
- Ascend Capital added most to Methanex in Q4 2014, an estimated $34.7M increase.
- Ascend Capital's biggest Q4 2014 reduction was Pfizer, cutting an estimated $48.7M.
- Ascend Capital fully exited Honeywell in Q4 2014, selling an estimated $87.2M.
- Ascend Capital's ten largest holdings make up 21% of its $2.61B portfolio in Q4 2014.
- Ascend Capital opened 65 new positions and closed 82 in Q4 2014.
- Ascend Capital's portfolio value fell 23% quarter-over-quarter to $2.61B.
Based on Ascend Capital's 13F filing for Q4 2014, filed 13 Feb 2015.